arrow
J

JinYu Guo

university of hong kong
H指数:12
被引数:474
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NSUNs-driven dysregulation: the next frontier in targeted cancer therapy?

NSUNs驱动的失调:靶向癌症治疗的下一个前沿?

2025-12-180
OAAI
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial

巩固性尼沃鲁单抗与观察对比在不可切除III期非小细胞肺癌患者中的应用,这些患者接受新辅助尼沃鲁单抗联合化疗及同步放化疗后(CA209-7AL):一项随机临床试验

2025-09-290
OAAI
Janus structured cellulose-based aerogel with vertical channels and conical roof for efficient solar-driven water evaporation and pollutant degradation

Janus结构纤维素基气凝胶,具有垂直通道和锥形屋顶,用于高效太阳光驱动水蒸发和污染物降解

2025-07-011
PRE
BOOST: a robust ten-fold expansion method on hour-scale

BOOST: 一种鲁棒性的十倍时级扩展方法

2025-03-020
OA
Comparing the outcomes of MR-based versus CT-based tumor delineation in locally advanced non-small cell lung cancer treated with hypo-fractionated radiotherapy and concurrent chemotherapy
2024-11-010
OAAI
Utilizing dual-responsive iridium(III) complex for hepatocellular carcinoma: Integrating photoacoustic imaging with chemotherapy and photodynamic therapy
2024-09-011
PRE
Engineering customized nanovaccines for enhanced cancer immunotherapy
2024-06-015
OAAI
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)
2023-10-016
PRE
Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: A prospective, single-arm phase II study (GASTO-1045)
2023-03-105
OAAI
Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer
2023-02-0112
PRE
Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
2022-11-183
OAAI
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment

基于CT影像组学的局部晚期非小细胞肺癌同步放化疗患者肿瘤及肿瘤机体环境特征的长期生存预测

2022-11-1626
OAAI
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies
2022-10-071
OAAI
Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes
2022-07-1126
PRE
Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapy
2022-03-014
PRE
Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial
2021-11-017
PRE
Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial
2021-10-0137
PREAI
Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase II Prospective Clinical Trial (GAST01011)
2021-09-0121
PRE